World Wires · story 11023 · unverified · 1 source(s)

Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa

Corvus Pharmaceuticals initiated its Phase 1b clinical trial of soquelitinib for the treatment of patients with hidradenitis suppurativa.

Open in the desk

Coverage

• Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa GlobeNewswire: public companies · tier D · clear net · 2026-09-30 20:05 UTC

What this site indexes